Australian Pharmacist

Despite being the most prevalent allergic disorder in Australia and New Zealand, allergic rhinitis is often underdiagnosed and undertreated.

PSA’s biggest ever national conference wrapped on Sunday 3 August after 3 full days of learning and networking.  The rainy weather didn’t stop more than...

At the peak of the COVID-19 pandemic, many pharmacists were faced with questions about treatment for which they felt they had no evidence-based answers.

A bumper field of 23 Australian pharmacists have been approved by the PSA National Board for elevation to fellow status.

Eczema affects up to 20% of children. Almost half of these patients develop eczema by the age of six months and most of them...

The expert witness testimony of Dr Janet Sluggett MPS at the aged care royal commission last year resulted in changes to the RMMR program.